Kemnay Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Kemnay Advisory Services's BMY Position: Q1 2026 in Review
Kemnay Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 27% in Q1 2026, selling an estimated $18K and leaving 820 shares worth $49.7K. The position accounts for 0.01% of the portfolio, ranked #259.
Kemnay Advisory Services first reported a position in BMY in Q4 2020 and has held it in 3 quarters since. The position peaked at $765K in Q4 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Kemnay Advisory Services held 820 shares of Bristol-Myers Squibb worth $49.7K as of Q1 2026.
- Kemnay Advisory Services sold 308 Bristol-Myers Squibb shares in Q1 2026, an estimated $18K.
- Bristol-Myers Squibb made up 0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #259 holding.
- Kemnay Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 3 quarters since.
- Kemnay Advisory Services's Bristol-Myers Squibb position peaked at $765K in Q4 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.